CLINICAL_TRIALS
withdrawal
· 2012-11-14
Clinical Trial Update: Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI
Summary
Memorial Sloan Kettering Cancer Center's clinical trial evaluating changes in background parenchymal enhancement and fibroglandular tissue on breast MRI has bee…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: WITHDRAWN